Suppr超能文献

全身 PET/MRI 中不同 MRI 序列在高危前列腺癌分期中的比较。

Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.

机构信息

1 Joint Department of Medical Imaging, Princess Margaret Hospital, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, 610 University Ave, Ste 3-960, Toronto, ON M5G 2M9, Canada.

出版信息

AJR Am J Roentgenol. 2019 Feb;212(2):377-381. doi: 10.2214/AJR.18.20495. Epub 2018 Oct 17.

Abstract

OBJECTIVE

The purpose of this study is to investigate the diagnostic value of various MRI sequences used for whole-body (WB) F-fluorocholine (FCH) PET/MRI staging of patients with high-risk prostate cancer (PCa).

SUBJECTS AND METHODS

This analysis is based on data from a prospective study that included 58 patients with untreated high-risk PCa who underwent integrated WB FCH PET/MRI (n = 10) or FCH PET/CT and WB MRI (n = 48). Metastatic sites were recorded. The standard of reference was histopathologic findings or clinical and imaging follow-up, or both. For each MRI sequence (Dixon T1-weighted, turbo inversion recovery magnitude, WB DWI, and gadolinium-enhanced T1-weighted volumetric interpolated breath-hold examination [VIBE]), acquisition time was recorded, and conspicuity of metastatic lesions was qualitatively assessed by two radiologists using a 4-point ordinal scale (0-3).

RESULTS

Total WB acquisition times were 1 minute 25 seconds for Dixon T1-weighted, 15 minutes 7 seconds for turbo inversion recovery magnitude, 16 minutes 33 seconds for WB DWI, and 1 minute 28 seconds for gadolinium-enhanced T1-weighted VIBE. The lesion detection rates were 88.3% (68/77) for Dixon T1-weighted, 94.8% (73/77) for turbo inversion recovery magnitude, 95.2% (40/42) for WB DWI, and 97.4% (75/77) for gadolinium-enhanced T1-weighted VIBE sequences. Moderate or high conspicuity scores were assigned to 62.3% (48/77) of lesions for Dixon T1-weighted, 88.3% (68/77) of lesions for turbo inversion recovery magnitude, 90.5% (38/42) of lesions for WB DWI, and 92.2% (71/77) of lesions for gadolinium-enhanced T1-weighted VIBE sequences. Conspicuity of metastases on gadolinium-enhanced T1-weighted VIBE and WB DWI sequences was higher than that on Dixon T1-weighted sequences (p < 0.0001 and p = 0.0011, respectively).

CONCLUSION

Metastases from prostate cancer are best detected at DWI or gadolinium-enhanced T1-weighted VIBE sequences. The most time-efficient sequence with the highest lesion detection rate and conspicuity is gadolinium-enhanced T1-weighted VIBE.

摘要

目的

本研究旨在探讨全身(WB)氟代胆碱(FCH)PET/MRI 分期中,各种 MRI 序列对高危前列腺癌(PCa)患者的诊断价值。

材料和方法

本分析基于前瞻性研究的数据,该研究纳入了 58 例未经治疗的高危 PCa 患者,这些患者接受了整合的 WB FCH PET/MRI(n=10)或 FCH PET/CT 和 WB MRI(n=48)检查。记录转移部位。参考标准为组织病理学发现或临床和影像学随访,或两者兼有。对于每个 MRI 序列(Dixon T1 加权、涡轮反转恢复幅度、WB DWI 和钆增强 T1 加权容积内插屏气检查[VIBE]),记录采集时间,并由两位放射科医生使用 4 分有序量表(0-3)对转移性病变的显影程度进行定性评估。

结果

Dixon T1 加权的总 WB 采集时间为 1 分 25 秒,涡轮反转恢复幅度为 15 分 7 秒,WB DWI 为 16 分 33 秒,钆增强 T1 加权 VIBE 为 1 分 28 秒。Dixon T1 加权、涡轮反转恢复幅度、WB DWI 和钆增强 T1 加权 VIBE 序列的病变检出率分别为 88.3%(68/77)、94.8%(73/77)、95.2%(40/42)和 97.4%(75/77)。Dixon T1 加权、涡轮反转恢复幅度、WB DWI 和钆增强 T1 加权 VIBE 序列的病变显影程度评分分别为 62.3%(48/77)、88.3%(68/77)、90.5%(38/42)和 92.2%(71/77)。转移灶在钆增强 T1 加权 VIBE 和 WB DWI 序列上的显影程度高于 Dixon T1 加权序列(p<0.0001 和 p=0.0011)。

结论

前列腺癌转移灶在 DWI 或钆增强 T1 加权 VIBE 序列上的检出率最高。具有最高病变检出率和显影程度的最省时序列是钆增强 T1 加权 VIBE。

相似文献

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验